Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Wells Fargo & Company's Rating of CME Group on 10/22/2026

On October 22, 2026, Wells Fargo & Company updated its outlook on CME Group (NASDAQ:CME) with the action "Boost Price Target", setting a price target of $333.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Wells Fargo & Company

DateCompanyAction
10/22/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Set Price Target
10/22/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
Lower Price Target
10/22/2026
Las Vegas Sands Corp. stock logo
LVS
Las Vegas Sands
Lower Price Target
10/22/2026
Reliance, Inc. stock logo
RS
Reliance
Boost Price Target
10/22/2026
Moody's Corporation stock logo
MCO
Moody's
Lower Price Target
10/22/2026
Annaly Capital Management Inc stock logo
NLY
Annaly Capital Management
Set Price Target
More Ratings From Wells Fargo & Company